Navigation Links
Women Health Expert GC-Rise Launches Obstetrician-gynecologist Prize
Date:7/31/2012

BEIJING, July 31, 2012 /PRNewswire-Asia/ -- GC-Rise Pharmaceutical Co. Ltd, in which European healthcare venture capital firm INVENTAGES holds a majority stake, has launched an obstetrician-gynecologist Honorary Award given to those who have done outstanding achievement in the medical community.

The company on July 15 held the first-ever GC-Rise-Cup ceremony in Hefei, capital city of central China's Anhui province, where awards were presented to 20 obstetrician-gynecologists chosen from around the country.

The 20 final award-winners stood out among 70 candidates after six months' open and fair appraisals by the selection committee.

The winners, with an average age of 80, include the expert who did the first test-tube baby in China, the doctor who was the first to advocate the importance of maternal and infant care and the one who was the first to promote the idea of painless delivery.

The prize, which compares to the 'OSCAR' in the medical industry, was jointly initiated by GC-Rise and China Medical Doctor Association, and is the first-ever and only award pointing to individuals in the medical circle in China.

The move aims to encourage the younger generations to inherit the spirits of the seniors, which shows GC-Rise's consistent commitment to play an active part in the women's health industry by joining hands with experts and professionals in the circle.

About GC-Rise Pharmaceutical Co. Ltd

GC-Rise Pharmaceutical Co. Ltd, established in 2008, is a wholly-owned foreign enterprise invested by INVENTAGES, a major European healthcare and biotechnology venture capital investor, focuses on women's health. Taking "Devoted to human healthcare and a better life" as our mission, the company makes full use of the business networks of our strategic partners in the United States, Europe and Japan, their rich experiences in clinical development, clinical trials and registration in China and their strong strength in distributions, hospital sales and marketing, so as to provide safe, novel and highly efficient medical products and treatment ideas for Chinese women patients.

Please log on http://www.gc-rise.com/ to know more information.



'/>"/>
SOURCE GC-Rise Pharmaceutical Co. Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
2. Relief from Menopause Symptoms Short-lived for Prempro Women Suffering from Cancers
3. What 20% of Women Want and Only 1% Get
4. IntelligentMDx Announces CE-Marking of a new high-throughput test for Group B Streptococcus intended to improve womens health and prenatal care
5. Viztek Announces Availability of Opal-Mammo Integrated Mammography Suite - Complete Womens Health Package Combines PACS and Tracking Software
6. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
7. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
8. Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women
9. Nouveau Life Pharmaceuticals (NOUV) Releases Krill Oil to Support Healthy Cholesterol Levels and Reduce Inflammation
10. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
11. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 According to the latest ... Market Study on Multiplex Detection Immunoassay: North America to ... global multiplex detection immunoassay market is expected to witness a CAGR ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
(Date:12/7/2016)... 2016 The global  blood ... of USD 3.9 billion by 2024, based on ... The growth of the market is attributed to ... advancements by the market players. Demand for blood ... donation, rising awareness about transfusion-transmitted diseases, and technological ...
(Date:12/6/2016)... 6, 2016  Alopexx Oncology, LLC announced data from ... fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting ... on B cells as Rituxan and maintains the activities ... also involved in tumor targeting, engagement of the immune ... results of the study (abstract #95954) were presented at ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending ... the unique opportunity to get hands-on experience in an emergency medical simulation, When ... experience to gain invaluable, real-life medical skills that are critical success in a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Children exposed to secondhand ... at the Icahn School of Medicine at Mount Sinai has found. The study ... young children are exposed to secondhand marijuana smoke, measurable amounts of primary metabolite ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... up with a schizophrenic mother in a unique, personal perspective through animation. ... treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, ...
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any lab to secure ... data. The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools ... need to operate in a GLP (Good Laboratory Practice) fashion. , With features designed ...
(Date:12/7/2016)... ... 2016 , ... Levels of a protein in the blood associated with heart ... in the journal Radiology. , Heart disease and brain disease exact a major burden ... aging population. Damage to both organs often occurs at a subclinical stage, or before ...
Breaking Medicine News(10 mins):